The Needle-free Injection System market in Saudi Arabia is expected to experience significant growth in 2032. This growth is driven by factors such as a growing demand for painless drug delivery, ...

The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$690.23 billion in 2025 and an impressive US$1,034.78 billion ...

The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$690.23 ...

There were significantly fewer adverse events associated with needle-free Tropis ® intradermal (ID) delivery as compared to needle and syringe (N/S). Tropis ID delivery was preferred over N/S ID ...

Refer to Instructions for Use to ensure safe injections and to review risks. 1 Resik, S et al, Tropis needle-free injector for fractional-dose IPV administration: A pilot study for integration ...

Now, a team of researchers from MIT and Singapore has developed a much more precise way to deliver substances to plants: tiny needles made ... from microneedle injections in plants, with no ...

The global intradermal injection market size is expected to surpass an impressive valuation ... Terumo Corporation is a pioneer in hypodermic needle innovation. The company offers a comprehensive ...

Following Bria-OTS intradermal injections every 2 weeks for six weeks (4 total doses), and subsequent dosing every 3 weeks, the lung metastasis completely resolved with stable disease elsewhere.